Stay updated on BBP-398 + Osimertinib in EGFR+ NSCLC: Clinical Trial

Sign up to get notified when there's something new on the BBP-398 + Osimertinib in EGFR+ NSCLC: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BBP-398 + Osimertinib in EGFR+ NSCLC: Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    Location details are reorganized: a new Locations section lists Beijing Municipality, Guangdong, Jilin, Shandong, and Sichuan as study sites; the prior separate location blocks are removed. The HHS Vulnerability Disclosure link is removed and the page revision is updated to v3.3.3.
    Difference
    0.7%
    Check dated 2025-12-18T20:40:59.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision: v3.3.2 replaces v3.2.0 on the page.
    Difference
    0.1%
    Check dated 2025-11-27T04:11:33.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Removed the government funding lapse notice from the page; no other content changes were made. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-19T22:10:41.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The screenshots indicate cosmetic/UI adjustments with no changes to core study details (eligibility criteria, primary outcomes, or status). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-29T10:08:58.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Introducing a major operational notice about funding status and updated versioning to v3.2.0, while removing the previous v3.1.0 reference.
    Difference
    4%
    Check dated 2025-10-07T23:09:52.000Z thumbnail image
  9. Check
    94 days ago
    Change Detected
    Summary
    Updated the page from Revision: v3.0.2 to Revision: v3.1.0, signaling a new software version.
    Difference
    0.1%
    Check dated 2025-09-30T01:36:52.000Z thumbnail image

Stay in the know with updates to BBP-398 + Osimertinib in EGFR+ NSCLC: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BBP-398 + Osimertinib in EGFR+ NSCLC: Clinical Trial page.